Table 1.
Clinicopathological characteristics of patient samples and expression of ACADL in ESCC
| Characteristics | Number of cases (%) |
|---|---|
|
| |
| Gender | |
| Female | 55 (40.7) |
| Male | 80 (59.3) |
| Age (years) | |
| >60 | 69 (51.1) |
| ≤60 | 66 (48.9) |
| Clinical stage | |
| I | 14 (10.4) |
| II | 80 (59.3) |
| III | 30 (22.2) |
| IV | 11 (8.1) |
| T classification | |
| T1 | 16 (11.9) |
| T2 | 52 (38.5) |
| T3 | 52 (38.5) |
| T4 | 15 (11.1) |
| N classification | |
| N0 | 91 (67.4) |
| N1 | 44 (32.6) |
| M classification | |
| No | 124 (91.9) |
| Yes | 11 (8.1) |
| Vital status (at follow-up) | |
| Alive | 72 (53.3) |
| Dead | 63 (46.7) |
| Histological differentiation | |
| Well | 36 (26.7) |
| Moderate | 74 (54.8) |
| Poor | 25 (18.5) |
| Expression of ACADL | |
| Low expression | 81 (60.0) |
| High expression | 54 (40.0) |
Abbreviations: ACADL, acyl-CoA dehydrogenase long chain; ESCC, esophagus squamous cell carcinoma.